Leading the way to safer medication
 Crosscheck  Recommender

ADENURIC

Found in: Austria Australia Cyprus Spain France Netherlands United Kingdom

Active Ingredients

#
Chemical substance
Description
1
Febuxostat

Uric acid is the end product of purine metabolism in humans and is generated in the cascade of hypoxanthine → xanthine → uric acid. Both steps in the above transformations are catalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative that achieves its therapeutic effect of decreasing serum uric acid by selectively inhibiting XO.

ATC Classification

Code
Title
Category
M04AA03
Febuxostat
M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AA Preparations inhibiting uric acid production

Product Monographs

Monograph
Type
Country
ADENURIC Film-coated tablet
MPI, EU: SmPC

Identifiers

Authority
Identifier(s)
Pharmaceutical Benefits Scheme (AU)
Identifier(s): 10445R
Z-Index G-Standaard PRK (NL)
Identifier(s): 101788, 101796
Base de données publique des médicaments (FR)
Identifier(s): 61871331, 64493890
Centro de información online de medicamentos de la AEMPS (ES)
Identifier(s): 08447001, 08447003